Molecular Detection of blaSHV-la Gene in Klebsiella pneumonia
Isolated from Urinary Tract Infections, Najaf, Iraqv
AuthorsMansor, M. R1, Ali Hasan Kashkool, D2, Safaa Abd Al-Ameer, S1, Akeel Al-Hasan, B1,
Almulla, A. F1
JournalRazi Vaccine & Serum Research Institute
AbstractKlebsiella pneumoniae is a gram-negative bacterium that causes serious illnesses, including pneumonia, liver
abscess, meningitis, bloodstream infections, and urinary tract infections (UTIs). This study aimed to isolate and
diagnose K. pneumoniae from clinical specimens of urine from patients with UTIs and perform molecular
detection of the blaSHV-la gene in K. pneumonia in the Najaf Province, Iraq. The study included 100 clinical
specimens from October 2021 to March 2022. As an initial diagnosis, K. pneumoniae isolates were diagnosed
based on culture and biochemical features. Apart from the usage of polymerase chain reaction (PCR)
technology to identify the blaSHV-la gene, the final diagnostic was achieved by the automated Vitek-2 compact
system. The biochemical findings revealed that 40 out of every 100 isolates tested positive for K. pneumoniae.
These results were validated by Vitek, which revealed that 40/100 of the samples tested positive for K.
pneumoniae, and by PCR utilizing the blaSHV-la gene, which showed that 13/40 of the samples tested positive for
K. pneumoniae isolated from the urine of patients with UTIs. In conclusion, the results indicated that the use of
the Vitek-2 technique was required to confirm the accurate identification of the pathogen. Klebsiella
pneumoniae clinical isolates showed multidrug resistance to antibiotics commonly used to treat UTIs. The
blaSHV gene encoded for Extended-spectrum beta-lactam antibiotic was found almost in K. pneumoniae isolates.
Ebola virus: A global public health frightening
AuthorsKhitam F. Abbas1, Layla Saleh Abdul-Hassan2, Sama S. Abd Al_Ameer3, Taghreed F. Almahbobi4, Ameer S. Alkhayyat5, Hujran Abdulraheem Abed6, Oday Mitib Hadi7, Baraa Akeel Al-Hasan8, Maryam. R. Mansor9, Estabraq Hassan Badder Al-Muhanna10
JournalJournal of Pharmaceutical Negative Results
AbstractEbola virus causes disease, previously known as the hemorrhagic fever, is a menace routinely lethal sickness triggered by infection per the Filoviridae family's Ebola virus. The Ebola virus (EBOV) is feast by commerce by means of the blood or bodily fluids of someone who has contracted or died from EVD, as well as contaminated things like as needles, animals that was infected, otherwise bush meat. EVD takes two days to three weeks’ incubation period then an rushed inception devoid of the need for a carrier status. A flu-like syndrome is characterized by a rapid onset of high fever, chills, and myalgia, among other clinical signs. It's generally identified by a combination of clinical symptoms, including start of disease, high fevers lasting fewer than 3 weeks, and as a minimum 2 hemorrhagic symptoms in spite of no predisposing causes. This is usually enough evidence for physicians to suspect EHF and start supportive therapy until test findings confirm the virus. Patients first show with nonspecific influenza similar symptoms before succumbing to shock and several organ failures. severe bleeding problems and several organ failures are the leading causes of death. For the reason that there is presently not any conventional rehabilitation for EVD, this one is perilous to minimize contagion and the virus's transmission. Supportive treatment for patients includes maintaining fluid balance, electrolyte balance, hypertension, and oximetry, beside that treatment consequences arise after secondary infections. This review gives a comprehensive summary of the Ebola virus.
APPEARANCE OF MULTIDRUG-RESISTANT FOR PSEUDOMONAS
AERUGINOSA : A REVIEW
AuthorsKhitam. F. Abbas1, Layla S. Al-mammouri2, Ameer S. Alkhayyat3, Sama S. Abd Al_Ameer4
and Rusul I. Mohsin5
JournalBiochem. Cell. Arch.
AbstractPseudomonas aeruginosa individuals whom is resistant and multidrug-resistant (MDR) are becoming
increasingly prevalent, posing a major public health risk. Infections by P. aeruginosa are hard to treatment those because its
inherent resistance toward several antibiotics (b-lactam and also penem antibiotics) besides these bacteria have ability to obtain
additional resistance mechanisms to multiple classes of antibiotics. In the direction of maintain genetic flexibility, many
techniques were utilized in the molecular process. The most frequent strategies employed by microorganisms to preserve their
viability include development of biofilm, quorum sensing, plus transfer of gene. Such genetic flexibility gives a variety of
advantages, including a favorable environment for growth and survival in the face of antibiotic stress. This review focuses on
Pseudomonas aeruginosa resistance mechanisms and treatment alternatives.
Molecular Detection of Beta-Lactamase Genes (KPC and CTX-M) of
Pseudomonas aeruginosa in Diabetic Foot Ulcers Patients
AuthorsFatima Radawi Almashhady, Sama S. Abd Al-Ameer2
,Hashim Mohammed
Hashim Al-aaraji3, and Khitam F. Abbas4
JournalMedical Science Journal for Advance Research
Abstractdiabetic foot ulcers (DFUs ) are an inflammatory disease caused by a bacterial
infection such as Pseudomonas aeruginosa (P. aeruginosa), provided with genetic virulence factors.
This study aims to detect KPC and CTX-M genes of P. aeruginosa isolated from chronic DFU
patients